(*) CA Approval Date: 2022. 08.11
(*) JP Approval Date: 2022. 08.25
(*) USA Approval Date: 2022. 03.11
>gBRCAm>Adjuvant Treat.>PARP Inh. T
Companion Diagnostics>
Company
gBRCAm: germline BRCA mutated
Generic Name: Olaparib
PARP: Poly ADP Ribose Polymerase
Patent>Assignee; Claims; No.; Etc.
RTM
RTM Web-Site